SK285868B6 - Spôsob získania vysokočistých inhibítorov HMG-CoAreduktázy - Google Patents

Spôsob získania vysokočistých inhibítorov HMG-CoAreduktázy Download PDF

Info

Publication number
SK285868B6
SK285868B6 SK2002-2000A SK20022000A SK285868B6 SK 285868 B6 SK285868 B6 SK 285868B6 SK 20022000 A SK20022000 A SK 20022000A SK 285868 B6 SK285868 B6 SK 285868B6
Authority
SK
Slovakia
Prior art keywords
mobile phase
hmg
coa reductase
column
fractions
Prior art date
Application number
SK2002-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK20022000A3 (sk
Inventor
Rok Grahek
Dusan Milivojevic
Andrej Bastarda
Original Assignee
Lek Pharmaceutical And Chemical Company D.D.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceutical And Chemical Company D.D. filed Critical Lek Pharmaceutical And Chemical Company D.D.
Publication of SK20022000A3 publication Critical patent/SK20022000A3/sk
Publication of SK285868B6 publication Critical patent/SK285868B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/422—Displacement mode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C07C67/52—Separation; Purification; Stabilisation; Use of additives by change in the physical state, e.g. crystallisation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
SK2002-2000A 1998-09-18 1999-09-17 Spôsob získania vysokočistých inhibítorov HMG-CoAreduktázy SK285868B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SI9800241A SI20072A (sl) 1998-09-18 1998-09-18 Postopek za pridobivanje inhibitorjev HMG-CoA reduktaze
PCT/IB1999/001553 WO2000017182A1 (en) 1998-09-18 1999-09-17 PROCESS FOR OBTAINING HMG-CoA REDUCTASE INHIBITORS OF HIGH PURITY

Publications (2)

Publication Number Publication Date
SK20022000A3 SK20022000A3 (sk) 2001-08-06
SK285868B6 true SK285868B6 (sk) 2007-10-04

Family

ID=20432332

Family Applications (1)

Application Number Title Priority Date Filing Date
SK2002-2000A SK285868B6 (sk) 1998-09-18 1999-09-17 Spôsob získania vysokočistých inhibítorov HMG-CoAreduktázy

Country Status (22)

Country Link
US (1) US6695969B1 (sl)
EP (1) EP1114040B1 (sl)
JP (1) JP3795755B2 (sl)
KR (1) KR100607608B1 (sl)
CN (1) CN1186335C (sl)
AT (1) ATE284396T1 (sl)
AU (1) AU766630B2 (sl)
BG (1) BG64676B1 (sl)
CA (1) CA2343645A1 (sl)
DE (1) DE69922519T2 (sl)
HR (1) HRP20010045B1 (sl)
HU (1) HUP0102997A2 (sl)
IL (2) IL142056A0 (sl)
IS (1) IS2149B (sl)
NZ (1) NZ509582A (sl)
PL (1) PL200336B1 (sl)
RO (1) RO121116B1 (sl)
RS (1) RS49996B (sl)
RU (1) RU2235098C2 (sl)
SI (1) SI20072A (sl)
SK (1) SK285868B6 (sl)
WO (1) WO2000017182A1 (sl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141602B2 (en) * 1998-09-18 2006-11-28 Lek Pharmaceuticals D.D. Process for obtaining HMG-CoA reductase inhibitors of high purity
SI20305A (sl) * 1999-08-06 2001-02-28 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Kristali natrijeve soli pravastatina
HUP9902352A1 (hu) * 1999-07-12 2000-09-28 Gyógyszerkutató Intézet Kft. Eljárás pravasztatin mikrobiológiai előállítására
RU2002114072A (ru) * 1999-11-30 2004-07-20 Биогал Джиоджисзерджиар РТ (HU) Способ выделения соединений статина из ферментационного бульона
CA2394200C (en) * 1999-12-14 2006-10-03 Biogal Gyogyszergyar Rt. Novel forms of pravastatin sodium
JP2003525935A (ja) 2000-03-03 2003-09-02 ビオガル ジョジセルジャール アール テー． 低下したレベルの二量体不純物を伴うロバスタチン及びシンバスタチンの精製方法
US6936731B2 (en) 2000-10-05 2005-08-30 TEVA Gyógyszergyár Részvénytársaság Pravastatin sodium substantially free of pravastatin lactone and epi-pravastatin, and compositions containing same
CZ20031166A3 (cs) * 2000-10-05 2004-04-14 Biogal Gyogyszergyar Rt Sodná sůl pravastatinu, která v podstatě neobsahuje pravastatin lakton a epi-pravastatin a kompozice na její bázi
US20050215636A1 (en) * 2000-10-05 2005-09-29 Vilmos Keri Pravastatin sodium substantially free of pravastatin lactone and EPI-pravastatin, and compositions containing same
KR100407758B1 (ko) * 2001-08-27 2003-12-01 씨제이 주식회사 스타틴의 제조에 있어서 락톤화 방법
JP2003093045A (ja) * 2001-09-26 2003-04-02 Godo Shusei Co Ltd 有用変換微生物
KR100435078B1 (ko) * 2002-02-08 2004-06-09 종근당바이오 주식회사 심바스타틴의 정제방법
CA2521276A1 (en) * 2003-04-01 2004-10-14 Ranbaxy Laboratories Limited Fermentation process for the preparation of pravastatin
US6978908B2 (en) * 2003-09-15 2005-12-27 Gerber Products Company Drinking vessel with adjustable handles
PT1641447E (pt) * 2003-11-24 2008-12-10 Teva Gyogyszergyar Zartkoeruee Método de purificação da pravastatina
ES2239533B1 (es) * 2004-03-01 2006-12-16 Ercros Industrial, S.A. Procedimiento para la obtencion de compactina.
MX2007003652A (es) * 2004-09-28 2009-02-16 Teva Pharma Proceso para preparar formas de calcio de atorvastatina sustancialmente libre de impurezas.
CN102043030A (zh) * 2009-10-22 2011-05-04 北京万全阳光医学技术有限公司 一种用高效液相色谱法测定烟酸辛伐他汀缓释片有关物质的方法
CN102621238A (zh) * 2011-02-01 2012-08-01 北京北大维信生物科技有限公司 一种测定HMG-CoA还原酶抑制剂浓度的方法
CN105985244A (zh) * 2015-02-04 2016-10-05 北京北大维信生物科技有限公司 化合物、其分离方法、合成方法及用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
IT1232311B (it) 1989-09-04 1992-01-28 Sclavo Spa Metodo di purificazione di composti a struttura peptidica o pseudo peptidica a basso peso molecolare.
US5202029A (en) * 1991-03-13 1993-04-13 Caron Kabushiki Kaisha Process for purification of hmg-coa reductase inhibitors
AU661996B2 (en) * 1991-03-14 1995-08-17 Kabushiki Kaisha Ace Denken Stock control system
US5420024A (en) * 1993-05-11 1995-05-30 Merck & Co., Inc. Process for synthesis of acylated HMG-CoA reductase inhibitors from a lactone diol precursor using Candida cylindracea
US5427686A (en) * 1994-04-05 1995-06-27 Sri International Process for separating material from mixture using displacement chromatography
EP0877089A1 (en) * 1997-05-07 1998-11-11 Gist-Brocades B.V. HMG-CoA reductase inhibitor preparation process

Also Published As

Publication number Publication date
RO121116B1 (ro) 2006-12-29
KR20010099584A (ko) 2001-11-09
IS2149B (is) 2006-10-13
SI20072A (sl) 2000-04-30
JP2002526486A (ja) 2002-08-20
HUP0102997A2 (hu) 2001-12-28
HRP20010045A2 (en) 2001-12-31
EP1114040B1 (en) 2004-12-08
KR100607608B1 (ko) 2006-08-02
RU2235098C2 (ru) 2004-08-27
NZ509582A (en) 2003-10-31
AU766630B2 (en) 2003-10-23
SK20022000A3 (sk) 2001-08-06
HRP20010045B1 (en) 2005-08-31
DE69922519T2 (de) 2005-12-08
ATE284396T1 (de) 2004-12-15
IL142056A0 (en) 2002-03-10
AU5528499A (en) 2000-04-10
RS49996B (sr) 2008-09-29
IS5886A (is) 2001-03-12
YU81800A (sh) 2003-02-28
US6695969B1 (en) 2004-02-24
JP3795755B2 (ja) 2006-07-12
IL142056A (en) 2006-08-01
CA2343645A1 (en) 2000-03-30
CN1186335C (zh) 2005-01-26
DE69922519D1 (de) 2005-01-13
WO2000017182A1 (en) 2000-03-30
EP1114040A1 (en) 2001-07-11
BG105348A (en) 2001-11-30
PL345883A1 (en) 2002-01-14
CN1318063A (zh) 2001-10-17
BG64676B1 (bg) 2005-11-30
PL200336B1 (pl) 2008-12-31

Similar Documents

Publication Publication Date Title
SK285868B6 (sk) Spôsob získania vysokočistých inhibítorov HMG-CoAreduktázy
US20070032549A1 (en) Process for obtaining HMG-CoA reductase inhibitors of high purity
Mullett et al. Multidimensional on-line sample preparation of verapamil and its metabolites by a molecularly imprinted polymer coupled to liquid chromatography–mass spectrometry
Díaz-Cruz et al. LC–MS2 trace analysis of antimicrobials in water, sediment and soil
EP0578723B1 (en) PROCESS FOR PURIFICATION OF HMG-CoA REDUCTASE INHIBITORS
CZ297093B6 (cs) Zpusob izolace a cistení inhibitoru HMG-CoA reduktasy
CZ2001137A3 (cs) Způsob získání inhibitorů HMG-CoA reduktázy vysoké čistoty
CA2210987C (en) Chromatographic purification of vancomycin hydrochloride by the use of preparative hplc
CN116381068A (zh) 一种分离并检测玛巴洛沙韦中有关物质的高效液相色谱法
Newsome et al. A method for the determination of 2-imidazoline residues in food crops
AU7770098A (en) Process for the production of radioiodinated neuroreceptor agents
EP1603894B1 (en) Pharmacologically active novel dauer pheromone compound for controlling aging and stress and method for isolating and characterizing the same
USH328H (en) Purification of cephalosporins
Idowu et al. Rapid derivatization of alcohols with carboxylic-sulphonic mixed anhydrides for HPLC-UV/fluorescence analysis: application to the detection of dihydroqinghaosu (dqhs) and its metabolites in biological samples
Pérez et al. Advances in the Analysis of Pharmaceuticals in the Aquatic Environment
Kennedy et al. Effective methods for enantioselective analysis of glycidol derivatives by liquid chromatography
Yang et al. Process utilized oligo-β-cyclodextrin substituted agarose gel medium for efficient purification of paclitaxel from Taxus cuspidata
Otake et al. The structures of minor congeners of detoxin complex, the selective antagonist of blasticidin S1
EP4229026A1 (en) Process for the preparation of cannabidiol
Arjmand et al. 2, 4, 5-Trichlorophenoxyacetic acid. Synthesis and thin-layer chromatography properties of amino acid conjugates and gas-liquid chromatography and mass spectra of methyl ester derivatives
JPH10182503A (ja) 有機化合物の分離方法

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20090917